Second-Generation Antipsychotics Increase Risk of Pneumonia

0
Taiwanese researchers found that second-generation antipsychotics increased the risk of pneumonia in a sample of 33,024 inpatients. Read more              ...

Cognitive Therapy is Effective for Schizophrenia

0
Noting that antipsychotic medications and psychosocial interventions have shown limited efficacy, researchers from the University of Pennsylvania followed 60 low-functioning individuals with schizophrenia diagnoses...

“Colorado Responds Slowly to Psychotropic Drug Use Among Foster Kids”

0
The Denver Post writes "Colorado officials have known since at least 2007 that prescriptions and dosage levels of psychotropic drugs — which also include antidepressants, mood...

Imagining the Fall of Antipsychotics

0
John Read and Phil Thomas imagine the eventual confession and apology by pharmaceutical companies - twenty years from now - of the harm done...

“When Does That Go On Trial?”

0
1 Boring Old Man scrutinizes the evidence that Johnson & Johnson hid evidence of Risperdal's breast-growing properties, among other improper actions, concluding "The story...

Search Nursing Home Deficiency Reports

0
ProPublica offers an interactive tool that lets you search nursing home inspection reports for problems such as antipsychotic overprescribing.

Polypharmacy and Excessive Dosing

0
Researchers in Japan investigated 139 patients with schizophrenia diagnoses due to be discharged from 19 acute psychiatric units in Japanese hospitals. Polypharmacy and excessive...

Antipsychotic Polypharmacy Commonly Prescribed Ahead of Guidelines

0
In one day at a psychiatric hospital in Vitoria-Gasteiz, Spain, of the 201 patients admitted 172 were prescribed antipsychotic drugs and 47% of those were...

J&J Alleged To Hide Evidence That Risperdal Grows Boys’ Breasts

2
"A drug that was never meant for kids was illegally marketed to kids," said a lawyer for the plaintiff in opening remarks for the...

Louisiana Court Rejects J&J’s Bid to Throw Out $258 million Risperdal Award

5
The state appeals court of Lake Charles, Louisiana found that "the trial court was not manifestly erroneous in casting (Johnson & Johnson owner) Janssen...

Justice Department Raises J&J Settlement to $1.8 Billion

0
Following Johnson & Johnson's $158 million resolution with Texas several states have demanded higher payments, leading the U.S. Justice Department to raise its demand...

Pressuring Parents to Drug Children

0
Jim Gottstein on Pressuring Parents to Drug Children

Department of Defense Apologizes for Antipsychotic-Related Deaths

2
The Army Times reports on the Department of Defense's crackdown on off-label antipsychotics in the context of research showing a strong link between antipsychotics,...

Federal Regulators Urge Cuts in Antipsychotics for Seniors

1
An Office of the Inspector General report says that nearly nine out of 10 prescriptions for antipsychotics given to Medicare beneficiaries are for unapproved uses....

Sexual Side Effects of Medications in Young People

6
The effects of antidepressants and mood stabilizers on young people's psychosexual development receive little attention or research, says Kaitlin Bell Barnett (author of "Dosed:...

Arkansas AG Petitions Supreme Court Decision Favoring J&J

5
Saying that the Arkansas supreme court had departed from 170 years of precedent by deciding in favor of Johnson & Johnson on grounds not...

The Legal and Moral Issues of Drugging Children

0
Jim Gottstein’s presentation March 29, 2012 at the APA’s Humanistic Division. Mr. Gottstein talks about the the legal and moral issues of the massive number...

Senate Amendment Filed to Fight Inappropriate Antipsychotics in Nursing Homes

5
Senators Chuck Grassley of Iowa, Herb Kohl of Wisconsin and Richard Blumenthal of Connecticut filed an amendment to the Food and Drug Administration Safety...

Long-Term Antipsychotic Treatment Causes Brain Tissue Loss

0
In 211 patients studied for up to 14 years, Nancy Andreason et al. found measurable brain tissue loss associated with antipsychotic use. The results...

Closing Arguments Begin in Arkansas Risperdal Trial

3
Arkansas is asking for a minimum of $1.2 billion in fines for the 250,000 Risperdal prescriptions issued under its medicaid program. Fletch Trammel, lawyer...

Risperdal Plaintiffs Ask Judge to Unseal Clinical Studies Data

0
Attorneys representing about 300 lawsuits alleging that Risperdal causes enlargement of breast tissue in men have asked a Pennsylvania judge to unseal relevant clinical...

Pharma Prosecutions Begin to Pay for Themselves

0
In what may prove to be a tipping point for prosecutions against pharmaceutical companies, states are beginning to see their "enforcement efforts pay for...

Pa. Court Hears Arguments in Dismissed Risperdal Case

0
A lawyer for Pennsylvania urged seven justices of the Pa. Commonwealth Court yesterday to allow the state's case against Johnson & Johnson's subsidiary Janssen...